BCL11A intellectual developmental disorder: defining the clinical spectrum and genotype-phenotype correlations
Angela Peron(University of Milan), Aditi Shah Parikh(University of North Carolina at Chapel Hill), Andrea Accogli(Istituto Giannina Gaslini), Constance Smith‐Hicks(Kennedy Krieger Institute), Christiane Zweier(University Hospital of Bern), Kimberly A. Aldinger(Seattle Children's Hospital), Wendy D. Jones(Great Ormond Street Hospital for Children NHS Foundation Trust), Lynne M. Bird(University of California San Diego), Ping Yee Billie Au(University of Calgary), Darrah Haffner(Nationwide Children's Hospital), Laurence Faivre(Inserm), Constance Motter(Akron Children's Hospital), Christophe Philippe(Inserm), Parthiv Haldipur(Norcliffe Foundation), Roberta Battini(Fondazione Stella Maris), Luitgard Graul‐Neumann(Charité - Universitätsmedizin Berlin), Dawn Earl(Seattle Children's Hospital), Amanda Openshaw(University Hospitals of Cleveland), Jill Clayton‐Smith(St Mary's Hospital), Felice D’Arco(Great Ormond Street Hospital for Children NHS Foundation Trust), Ange‐Line Bruel(Inserm), Patrick Ferreira(Alberta Children's Hospital), Karen Low(North Bristol NHS Trust), Kimberly S. McDonald(Jackson Memorial Hospital), Michael J. Bamshad(University of Washington), Øyvind L. Busk(Telemark Hospital), Jenny Carmichael(Northampton General Hospital), Manuela Morleo(University of Campania "Luigi Vanvitelli"), Gunnar Houge(Haukeland University Hospital), Gyri Aasland Gradek(Guy's and St Thomas' NHS Foundation Trust), Daniah Beleford(University of California, San Francisco), Erica Andersen(University of Utah), Cornelia Kraus(Friedrich-Alexander-Universität Erlangen-Nürnberg), Sally Ann Lynch(University College Dublin), Anna Chassevent(Kennedy Krieger Institute), Janice C. Palumbos(University of Utah), Arjan Bouman(Erasmus MC), Birgit Elisabeth Kristiansen(Oslo University Hospital), Sofia Maia(Instituto Português de Oncologia Francisco Gentil), Mary J. Green(The Francis Crick Institute), Ruta Kalinauskiene(Guy's and St Thomas' NHS Foundation Trust), Philippe M. Campeau(Centre Hospitalier Universitaire Sainte-Justine), James Lespinasse(Centre Hospitalier Métropole Savoie), Suhair Hanna(Technion – Israel Institute of Technology), Catherine Melver(Newcastle upon Tyne Hospitals NHS Foundation Trust), Tara Montgomery(Newcastle upon Tyne Hospital), Colleen M. Carlston(Boston Children's Hospital), Kimberley Bradbury(Guy's and St Thomas' NHS Foundation Trust), Rong Mao(University of Utah)
Cited by 16
Related Papers
Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes
|New England Journal of Medicine|2008|811
Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments
|PLoS Genetics|2014|672
Angelman syndrome 2005: Updated consensus for diagnostic criteria
|American Journal of Medical Genetics Part A|2006|645
Characterization of human disease phenotypes associated with mutations in <i>TREX1</i>, <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, <i>SAMHD1</i>, <i>ADAR</i>, and <i>IFIH1</i>
|American Journal of Medical Genetics Part A|2015|617